STOCK TITAN

NewGenIVF (NIVF) reshapes investor note to increase financing flexibility

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

NewGenIVF Group Limited entered into an Amendment and Exchange Agreement with an institutional investor under which, on August 14, 2026, the investor’s existing convertible notes and related warrants were exchanged for a new senior convertible note with an aggregate principal amount of $7,105,468.75. A related Leak-Out Agreement restricts sales of Class A ordinary shares issuable upon conversion of the new note. The restructuring removed a prior requirement that a significant percentage of proceeds from new capital raises be used to prepay the notes under a June 16, 2026 Repurchase and Forbearance Agreement, and is described by the company as intended to provide greater flexibility in managing future financing and capital structure.

Positive

  • Exchange of existing securities into a new $7,105,468.75 senior convertible note removes a prior mandatory proceeds sweep, which the company states is intended to increase capital-raising flexibility.
  • A new Leak-Out Agreement limits the investor’s share sales after conversion, potentially reducing near-term selling pressure on the company’s Class A ordinary shares.

Negative

  • None.
New senior convertible note principal $7,105,468.75 Aggregate principal amount of the new senior convertible note issued August 14, 2026
Exchange Agreement date August 11, 2026 Date NewGenIVF entered into the Amendment and Exchange Agreement with the institutional investor
Exchange closing date August 14, 2026 Date on which the note exchange and Leak-Out Agreement became effective
Press release date August 17, 2026 Date NewGenIVF announced completion of the exchange transaction
Amendment and Exchange Agreement financial
"entered into an Amendment and Exchange Agreement with a certain institutional investor"
senior convertible note financial
"issued to the Holder a new senior convertible note in the aggregate principal"
A senior convertible note is a loan a company issues that sits near the top of its repayment order and can be exchanged for the company’s stock under set conditions. Think of it like a high-priority IOU that also includes a coupon you can choose to turn into shares instead of taking cash back. It matters to investors because it affects who gets paid first if the company struggles and can dilute existing shareholders if the notes convert into new shares.
Leak-Out Agreement financial
"the Holder also entered into a Leak-Out Agreement with the Company"
A leak-out agreement is a contract that lets a company share sensitive, non-public information with a limited set of outsiders under strict rules, effectively permitting a controlled ‘leak’ rather than broad disclosure. For investors this matters because it can speed up deal discussions or partner searches while setting who sees critical information, influencing the fairness of a process, potential stock-price reactions, and the risk of confidential information reaching the market prematurely.
mandatory proceeds sweep financial
"eliminates the prior mandatory requirement that a significant percentage of proceeds"
A mandatory proceeds sweep is a provision in a loan or credit agreement that requires a borrower to use certain incoming cash — typically from asset sales, insurance recoveries, or equity issuances — to pay down outstanding debt automatically instead of keeping the cash on hand. Think of it like a rule that diverts windfall money straight to paying off a mortgage; it matters to investors because it changes how much cash a company keeps for operations, growth, or dividends and can speed debt reduction or limit reinvestment options.
Repurchase and Forbearance Agreement financial
"prepay the notes under the Repurchase and Forbearance Agreement dated June 16, 2026"
A repurchase and forbearance agreement is a contract in which a borrower or seller agrees to buy back assets or repay a loan on set terms while the lender agrees to pause or delay collection actions for a defined period. For investors it signals a negotiated fix to preserve value and avoid immediate losses—like temporarily letting someone catch up on car payments while they promise to retake ownership later—so it affects credit risk, collateral recovery and near‑term liquidity.

FAQ

What capital structure change did NewGenIVF Group Limited (NIVF) announce on August 17, 2026?

NewGenIVF announced completion of an exchange in which an institutional investor’s existing convertible notes and related warrants were swapped for a new senior convertible note with principal of $7,105,468.75, on amended terms intended to improve capital structure flexibility.

What is the size of the new senior convertible note issued by NIVF in the August 2026 exchange?

The new senior convertible note issued to the institutional investor has an aggregate principal amount of $7,105,468.75. This note replaces the investor’s prior convertible notes that were subject to more restrictive provisions, including a mandatory proceeds sweep on new capital raises.

How did the NewGenIVF (NIVF) note exchange affect the mandatory proceeds sweep?

The restructuring eliminates the previous requirement that a significant percentage of proceeds from new capital raises be used to prepay the notes. This change, tied to a June 16, 2026 agreement, is described as enhancing NewGenIVF’s flexibility in future financing activity.

What is the Leak-Out Agreement mentioned in NewGenIVF’s August 2026 6-K?

The Leak-Out Agreement is an arrangement between NewGenIVF and the institutional investor that restricts sales of Class A ordinary shares issuable upon conversion of the new senior convertible note, establishing a leak-out framework to govern the timing and volume of potential share sales.

When did NewGenIVF (NIVF) close the exchange of convertible notes with the institutional investor?

The exchange of the investor’s existing convertible notes and related warrants for the new senior convertible note closed on August 14, 2026. NewGenIVF reported the transaction and filed the related agreements as exhibits in a subsequent Form 6-K.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-42004

 

NEWGENIVF GROUP LIMITED

(Exact name of registrant as specified in its charter)

 

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

EXPLANATORY NOTE

 

On August 11, 2026, NewGenIvf Group Limited (the “Company”) entered into an Amendment and Exchange Agreement (the “Exchange Agreement”) with a certain institutional investor (the “Holder”), pursuant to which on August 14, 2026, the Company issued to the Holder a new senior convertible note in the aggregate principal amount of $7,105,468.75 (the “New Note”) in exchange for the Holder’s existing convertible notes and related warrants previously issued by the Company to the Holder. In connection with the Exchange Agreement, on August 14, 2026, the Holder also entered into a Leak-Out Agreement with the Company (the “Leak-Out Agreement”) restricting the Holder’s sales of the Company’s Class A ordinary shares issuable upon conversion of the New Note.

 

On August 17, 2026, the Company issued a press release announcing its entry into the Exchange Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The foregoing descriptions of the Exchange Agreement, the New Note and the Leak-Out Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, copies of which are filed herewith as Exhibits 10.1, 10.2 and 10.3, respectively, and are incorporated herein by reference.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
10.1   Amendment and Exchange Agreement, dated August 11, 2026, by and between NewGenIvf Group Limited and the Holder
10.2   Form of Senior Convertible Note issued by NewGenIvf Group Limited to the Holder
10.3   Form of Leak-Out Agreement, dated August 14, 2026, by and between NewGenIvf Group Limited and the Holder
99.1   Press Release

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: August 17, 2026

 

  NEWGENIVF GROUP LIMITED
     
  By: /s/ Wing Fung Alfred Siu
  Name: Wing Fung Alfred Siu
  Title: Chairman of the Board and Director

 

3

 

Exhibit 99.1

 

NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor

 

Restructuring eliminates prior mandatory proceeds sweep and improves capital structure flexibility

 

BANGKOK, August 17, 2026 – NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.

 

The restructuring eliminates the prior mandatory requirement that a significant percentage of proceeds from new capital raises be applied to prepay the notes under the Repurchase and Forbearance Agreement dated June 16, 2026, which was disclosed in the Company’s Form 6-K filing on June 16, 2026. The new note also incorporates a leak-out framework and other modified terms intended to provide greater flexibility for the Company. The full agreement will be filed as an exhibit to the Company's Report on Form 6-K, which will be furnished to the U.S. Securities and Exchange Commission simultaneously with this press release.

 

“This exchange represents an important step in improving the terms of our capital structure,” said Alfred Siu, Founder, Chairman and CEO of NewGen. “By removing the previous mandatory proceeds sweep and establishing more constructive terms, we enhance our ability to manage future financing activity in a manner that better supports the Company’s strategic objectives and long-term growth.”

 

The Company continues to evaluate additional opportunities to further optimize its capital structure in a manner consistent with shareholder interests.

 

About NewGen

 

NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.

 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding: the anticipated benefits of the exchange of the Investor's existing convertible notes for a new senior convertible note on amended terms, including the elimination of the prior mandatory proceeds sweep and the leak-out framework and other modified terms intended to provide greater flexibility for the Company; the Company's ability to manage future financing activity in a manner that supports its strategic objectives and long-term growth; and the Company's plans to continue evaluating additional opportunities to optimize its capital structure.

 

These forward-looking statements are based on the Company's current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: risk relating to the Company's convertible note financing arrangements, including compliance with associated covenants and the risk of default; share dilution and capital markets issuance risk; and liquidity and capital requirements risk. Additional risks are described in the Company's Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.

 

All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable securities laws.

 

 

Contacts

ICR, LLC

Robin Yang

Phone: +1 (212) 537-3847

Email: Newgenivf.IR@icrinc.com

 

 

Filing Exhibits & Attachments

4 documents